Anti-tumor activity of three ginsenoside derivatives in lung cancer is associated with Wnt/β-catenin signaling inhibition
- 1 November 2014
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 742, 145-152
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- AD-1, a novel ginsenoside derivative, shows anti-lung cancer activity via activation of p38 MAPK pathway and generation of reactive oxygen speciesBiochimica et Biophysica Acta (BBA) - General Subjects, 2013
- Effect of extracts from Phyllanthus watsonii Airy Shaw on cell apoptosis in cultured human breast cancer MCF-7 cellsExperimental and Toxicologic Pathology, 2013
- Synthesis and anti-tumor evaluation of novel 25-hydroxyprotopanaxadiol analogs incorporating natural amino acidsSteroids, 2013
- Decorin-mediated inhibition of colorectal cancer growth and migration is associated with E-cadherin in vitro and in miceCarcinogenesis, 2011
- Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapyCell Death & Differentiation, 2011
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Anticancer activity of Panax notoginseng extract 20(S)‐25‐OCH3‐PPD: Targetting β‐catenin signallingClinical and Experimental Pharmacology and Physiology, 2009
- Anti-lung cancer effects of novel ginsenoside 25-OCH3-PPDLung Cancer, 2009
- Novel ginsenosides 25-OH-PPD and 25-OCH 3 -PPD as experimental therapy for pancreatic cancer: anticancer activity and mechanisms of actionCancer Letters, 2009
- Structure-Activity Relationship and Substrate-Dependent Phenomena in Effects of Ginsenosides on Activities of Drug-Metabolizing P450 EnzymesPLOS ONE, 2008